- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT03560726
Telehealth Cognitive Behavioral Stress Management for Adults With Cystic Fibrosis
Обзор исследования
Статус
Вмешательство/лечение
Тип исследования
Регистрация (Действительный)
Фаза
- Непригодный
Контакты и местонахождение
Места учебы
-
-
Colorado
-
Denver, Colorado, Соединенные Штаты, 80206
- National Jewish Health
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
- At least 18 years old
- Fluent in English
- Diagnosed with Cystic Fibrosis
- Colorado resident
- Access to personal device (smart phone, computer, tablet) with 1) reliable internet connection, and 2) a built-in web camera and microphone or the capability to install a study-provided web camera and microphone
- Regular access to a private location with sufficient lighting that is free from distractions or intrusions to use during telehealth sessions
- Access to private email to complete surveys
- Mild anxiety and/or depression symptoms (i.e., a score of 5 or higher on the Generalized Anxiety Disorder 7 Item Scale (GAD-7) and/or the Patient Health Questionnaire 9 Item Scale (PHQ-9))
Exclusion Criteria:
- Currently receiving therapy or counseling with an outside provider for a mental health condition
- Currently in treatment for alcohol or substance abuse
- Unstable medical condition (not including cystic fibrosis)
- Neurological disease
- Pregnant women
- Active suicidal intent or plan (a score of 1 or higher on the Suicide Severity Scale)
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Поддерживающая терапия
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Нет (открытая этикетка)
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: Telehealth
Participants randomized into the telehealth arm will receive up to 7 one-hour telehealth visits with the study psychologist.
The first six sessions will focus on cognitive behavioral stress management topics and the seventh session is optional, focusing on lung transplant readiness.
Participants will fill out questionnaires every other week (baseline, week 2, week 4, week 6, week 8) and during a 3-month follow-up (week 20).
Participants will wear an actigraphy watch to track sleep and movement for one week at a time during baseline, week 8, and week 20.
|
Cognitive behavioral stress management is a well-established, practical intervention that combines elements of cognitive behavioral therapy with techniques designed to improve coping skills, social support, communication, and relaxation/mindfulness.
|
|
Без вмешательства: Treatment-As-Usual (TAU)
Participants randomized into the TAU arm will not receive any telehealth visits during the 8-week intervention phase. Participants will fill out questionnaires every other week (baseline, week 2, week 4, week 6, week 8) and during a 3-month follow-up (week 20). Participants will wear an actigraphy watch to track sleep and movement for one week at a time during baseline, week 8, and week 20. |
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Feasibility (patient perspective)
Временное ограничение: Week 0 (baseline)
|
Assess the feasibility of telehealth-delivered Cognitive Behavioral Stress Management from the patient perspective using participation rates (i.e., number of people interested and consented into the study).
|
Week 0 (baseline)
|
|
Feasibility (clinician perspective)
Временное ограничение: Week 8
|
Assess the feasibility of telehealth-delivered Cognitive Behavioral Stress Management from the clinician perspective using the Structured Assessment of Feasibility (SAFE; 16 items).
The first 8 items provide information about barriers to implementation and the second 8 items provide information about enablers to implementation.
It is recommended that no overall summary score be used, as this scale is designed to highlight barriers and facilitators that future programs should consider if they decide to continue or begin implementing this intervention.
|
Week 8
|
|
Acceptability (patient perspective 1 of 2)
Временное ограничение: Week 8
|
Assess the acceptability of telehealth-delivered Cognitive Behavioral Stress Management from the patient perspective using participation rates (i.e., telehealth sessions completed, dropouts).
|
Week 8
|
|
Acceptability (patient perspective 2 of 2)
Временное ограничение: Week 8
|
Assess the acceptability of telehealth-delivered Cognitive Behavioral Stress Management from the patient perspective using the Acceptability Scale (12 items; 5 = strongly agree, 1 = strongly disagree), which was adapted specifically for this study.
A mean acceptability score will be computed from these 12 items.
|
Week 8
|
|
Satisfaction (patient perspective 1 of 2)
Временное ограничение: Week 8
|
Assess the satisfaction of telehealth-delivered Cognitive Behavioral Stress Management from the patient perspective.
Satisfaction measured using the Satisfaction Scale (8 items; 5 = strongly agree, 1 = strongly disagree), which was adapted specifically for this study.
A mean satisfaction score will be computed from the 8 items.
|
Week 8
|
|
Satisfaction (patient perspective 2 of 2)
Временное ограничение: Week 8
|
Assess the satisfaction of telehealth-delivered Cognitive Behavioral Stress Management from the patient perspective using 4 open-ended questions designed specifically for this study.
A qualitative summary will be provided based on responses to the open ended questions.
|
Week 8
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Anxiety symptom improvement
Временное ограничение: Week 0, 2, 4, 6, 8, 20
|
Assess changes in anxiety throughout study using the Generalized Anxiety Disorder 7-item Scale (GAD-7), which asks participants to rate how much they have been bothered by anxiety symptoms over the past 2 weeks (7 items, 0 = not at all, 1= several days, 2= more than half the days 3 = nearly every day).
A total score will be created by summing the scores of the 7 items.
|
Week 0, 2, 4, 6, 8, 20
|
|
Depression symptom improvement
Временное ограничение: Week 0, 2, 4, 6, 8, 20
|
Assess changes in depression throughout study using the Patient Health Questionnaire 9-item Scale (PHQ-9), which asks participants to rate how much they have been bothered by depression symptoms over the past 2 weeks (9 items, 0 = not at all, 1= several days, 2= more than half the days 3 = nearly every day).
A total score will be created by summing the scores of the 9 items.
|
Week 0, 2, 4, 6, 8, 20
|
Соавторы и исследователи
Спонсор
Следователи
- Главный следователь: CJ Bathgate, PhD, National Jewish Health
Публикации и полезные ссылки
Даты записи исследования
Изучение основных дат
Начало исследования (Действительный)
Первичное завершение (Действительный)
Завершение исследования (Действительный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- 3143
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .